Ethics of Clinical Trials in Low-Resource Settings: Lessons From Recent Trials in Cancer Medicine.
作者信息
Prasad Vinay, Kumar Hemanth, Mailankody Sham
机构信息
National Cancer Institute, Bethesda, MD, and Oregon Health and Sciences University, Portland, OR.
Goa Medical College, Goa, India.
出版信息
J Glob Oncol. 2015 Dec 23;2(1):1-3. doi: 10.1200/JGO.2015.000885. eCollection 2016 Feb.
Abstract
摘要
相似文献
1
Ethics of Clinical Trials in Low-Resource Settings: Lessons From Recent Trials in Cancer Medicine.资源匮乏地区临床试验的伦理：癌症医学近期试验的经验教训。
J Glob Oncol. 2015 Dec 23;2(1):1-3. doi: 10.1200/JGO.2015.000885. eCollection 2016 Feb.
2
Suggestions for health information technology trials for respiratory disorders in low- and middle-income country settings: what can we learn from trials in high-income country settings?低、中收入国家呼吸系统疾病卫生信息技术试验建议：我们能从高收入国家的试验中学到什么？
NPJ Prim Care Respir Med. 2015 Jul 9;25:15045. doi: 10.1038/npjpcrm.2015.45.
3
Critical care in resource-poor settings: lessons learned and future directions.资源匮乏环境下的重症监护：经验教训与未来方向。
Crit Care Med. 2011 Apr;39(4):860-7. doi: 10.1097/CCM.0b013e318206d6d5.
4
Rethinking medical ethics: a view from below.重新思考医学伦理：自下而上的视角。
Dev World Bioeth. 2004 May;4(1):17-41. doi: 10.1111/j.1471-8731.2004.00065.x.
5
Ethics.伦理学
JAMA. 1990 May 16;263(19):2641-2.
6
'The demolition of a man': lessons from Holocaust literature for the teaching of nursing ethics.“人的毁灭”：大屠杀文学对护理伦理教学的启示
Nurs Ethics. 2004 Mar;11(2):138-49. doi: 10.1191/0969733004ne679oa.
7
Medicine and the Holocaust--lessons for present and future physicians.医学与大屠杀——给当代及未来医生的教训
Med Law. 2008 Dec;27(4):787-804.
8
Ethics in critical care medicine: conclusions.
Crit Care Clin. 1986 Jan;2(1):183-6.
9
Real-time Responsiveness for Ethics Oversight During Disaster Research.灾难研究期间伦理监督的实时响应能力
Bioethics. 2015 Nov;29(9):653-61. doi: 10.1111/bioe.12193.
引用本文的文献
1
Global patterns of hemophilia drug trials, hemophilia care, and health care measures.血友病药物试验、血友病护理及医疗保健措施的全球模式。
Res Pract Thromb Haemost. 2025 Feb 27;9(2):102714. doi: 10.1016/j.rpth.2025.102714. eCollection 2025 Feb.
2
Chasing 'vulnerability' across six decades of the Declaration of Helsinki.在六十年的《赫尔辛基宣言》历程中追寻“脆弱性”
Monash Bioeth Rev. 2025 Jun;43(1):1-33. doi: 10.1007/s40592-025-00235-4. Epub 2025 Feb 25.
3
Challenges and opportunities for cancer clinical trials in low- and middle-income countries.低收入和中等收入国家癌症临床试验面临的挑战与机遇
Nat Cancer. 2020 Feb;1(2):142-145. doi: 10.1038/s43018-020-0030-x.
4
Cancer drug development: The missing links.癌症药物研发：缺失的环节。
Exp Biol Med (Maywood). 2019 May;244(8):663-689. doi: 10.1177/1535370219839163. Epub 2019 Apr 8.
5
Researchers' First Duty Is to the Participants.
J Glob Oncol. 2016 May 18;2(4):246-247. doi: 10.1200/JGO.2016.005058. eCollection 2016 Aug.
6
The Landscape of Randomised Controlled Trials of Therapies in Breast Cancer in Low and Middle Income Countries.低收入和中等收入国家乳腺癌治疗随机对照试验的概况
Int J Breast Cancer. 2017;2017:4259704. doi: 10.1155/2017/4259704. Epub 2017 Apr 9.
本文引用的文献
1
Ethics of cancer clinical trials in low-resource settings.资源匮乏地区癌症临床试验的伦理问题。
J Clin Oncol. 2014 Oct 1;32(28):3192-6. doi: 10.1200/JCO.2014.56.9780. Epub 2014 Sep 2.
2
Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India.初级卫生工作者进行阴道镜检查（VIA）筛查的效果：印度孟买的随机对照研究。
J Natl Cancer Inst. 2014 Mar;106(3):dju009. doi: 10.1093/jnci/dju009. Epub 2014 Feb 22.
3
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.阿法替尼对比顺铂加吉西他滨用于治疗亚洲表皮生长因子受体突变阳性的晚期非小细胞肺癌患者的一线治疗（LUX-Lung 6）：一项开放标签、随机、III 期临床试验。
Lancet Oncol. 2014 Feb;15(2):213-22. doi: 10.1016/S1470-2045(13)70604-1. Epub 2014 Jan 15.
4
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.《世界医学协会赫尔辛基宣言：涉及人类受试者的医学研究伦理原则》
JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053.
5
Ethics of 'standard care' in randomised controlled trials of screening for cervical cancer.子宫颈癌筛查随机对照试验中“标准护理”的伦理学问题
Indian J Med Ethics. 2013 Jul-Sep;10(3):147-9. doi: 10.20529/IJME.2013.048.
6
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.III 期研究阿法替尼或顺铂加培美曲塞治疗 EGFR 突变的转移性肺腺癌患者。
J Clin Oncol. 2013 Sep 20;31(27):3327-34. doi: 10.1200/JCO.2012.44.2806. Epub 2013 Jul 1.
7
Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.拉帕替尼联合紫杉醇治疗人表皮生长因子受体 2 过表达转移性乳腺癌的随机试验。
J Clin Oncol. 2013 Jun 1;31(16):1947-53. doi: 10.1200/JCO.2011.40.5241. Epub 2013 Mar 18.
8
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis.1980 年至 2010 年 187 个国家的乳腺癌和宫颈癌：系统分析。
Lancet. 2011 Oct 22;378(9801):1461-84. doi: 10.1016/S0140-6736(11)61351-2. Epub 2011 Sep 14.
9
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.吉非替尼或卡铂-紫杉醇用于治疗肺腺癌。
N Engl J Med. 2009 Sep 3;361(10):947-57. doi: 10.1056/NEJMoa0810699. Epub 2009 Aug 19.
Zotero 插件